BBVA USA’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
Other funds holding PBH
TCAM
BBVA USA's PBH Position: Q3 2021 in Review
BBVA USA reduced its Prestige Consumer Healthcare (PBH) stake by 1.3% in Q3 2021, selling an estimated $5.93K and leaving 8,456 shares worth $475K. The position accounts for 0.03% of the portfolio, ranked #339.
BBVA USA first reported a position in PBH in Q2 2021 and has held it in 2 quarters since. 248 funds tracked by Wall St. Rank hold PBH as of Q3 2021.
- BBVA USA held 8,456 shares of Prestige Consumer Healthcare worth $475K as of Q3 2021.
- BBVA USA sold 108 Prestige Consumer Healthcare shares in Q3 2021, an estimated $5.93K.
- Prestige Consumer Healthcare made up 0.03% of BBVA USA's portfolio in Q3 2021, its #339 holding.
- BBVA USA first reported a position in Prestige Consumer Healthcare in Q2 2021 and has held it in 2 quarters since.
- 248 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2021.
Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.